Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 24 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Fluorouracil  [Clear All Filters]
2019
Pentheroudakis, G., Mavroeidis L., Papadopoulou K., Koliou G-A., Bamia C., Chatzopoulos K., et al. (2019).  Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.. Clin Colorectal Cancer. 18(4), e370-e384.
2018
Pentheroudakis, G., Kotoula V., Koliou G-A., Karavasilis V., Samantas E., Aravantinos G., et al. (2018).  AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.. Clin Colorectal Cancer. 17(4), e631-e637.
2016
Cohen, S. A., Wu C., Yu M., Gourgioti G., Wirtz R., Raptou G., et al. (2016).  Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.. Clin Colorectal Cancer. 15(2), 164-9.
2015
Saridaki, Z., Lambrodimou G., Kachris S., Makrantonakis P., Boukovinas I., Polyzos A., et al. (2015).  Postoperative treatment with docetaxel, cisplatin, and capecitabine (DCX) and chemoradiotherapy (CRT) with capecitabine for resected gastric adenocarcinoma.. Am J Clin Oncol. 38(1), 17-22.
Pectasides, D., Karavasilis V., Papaxoinis G., Gourgioti G., Makatsoris T., Raptou G., et al. (2015).  Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or. BMC Cancer. 15, 384.
Stamou, K., Tsamis D., Pallas N., Samanta E., Courcoutsakis N., Prassopoulos P., et al. (2015).  Treating peritoneal mesothelioma with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A case series and review of the literature.. Int J Hyperthermia. 31(8), 850-6.
2014
Dermitzakis, E. V., Kimiskidis V. K., Eleftheraki A., Lazaridis G., Konstantis A., Basdanis G., et al. (2014).  The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system.. Eur J Neurol. 21(12), 1471-7.
2013
Apalla, Z., Lallas A., Sotiriou E., & Ioannides D. (2013).  Effect of pigmentation on photodynamic therapy.. Lancet Oncol. 14(9), e339-40.
Darwiche, K., Zarogoulidis P., Karamanos N. K., Domvri K., Chatzaki E., Constantinidis T. C., et al. (2013).  Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.. Future Oncol. 9(4), 505-25.
Crown, J. P., Diéras V., Staroslawska E., Yardley D. A., Bachelot T., Davidson N., et al. (2013).  Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.. J Clin Oncol. 31(23), 2870-8.
2012
Fountzilas, G., Dafni U., Bobos M., Batistatou A., Kotoula V., Trihia H., et al. (2012).  Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.. PLoS One. 7(6), e37946.
Xenidis, N., Chelis L., Amarantidis K., Chamalidou E., Dimopoulos P., Courcoutsakis N., et al. (2012).  Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study.. Cancer Chemother Pharmacol. 69(2), 477-84.
Razis, E., Kalogeras K. T., Kotoula V., Eleftheraki A. G., Nikitas N., Kronenwett R., et al. (2012).  Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.. Clin Breast Cancer. 12(3), 183-93.
Zarogoulidis, P., Chatzaki E., Hohenforst-Schmidt W., Goldberg E. P., Galaktidou G., Kontakiotis T., et al. (2012).  Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.. Cancer Gene Ther. 19(9), 593-600.
Gogas, H., Dafni U., Karina M., Papadimitriou C., Batistatou A., Bobos M., et al. (2012).  Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.. Breast Cancer Res Treat. 132(2), 609-19.
Psyrri, A., Kalogeras K. T., Kronenwett R., Wirtz R. M., Batistatou A., Bournakis E., et al. (2012).  Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.. Ann Oncol. 23(6), 1422-7.
Pectasides, D., Papaxoinis G., Kalogeras K. T., Eleftheraki A. G., Xanthakis I., Makatsoris T., et al. (2012).  XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.. BMC Cancer. 12, 271.
2011
Kanellos, D., Pramateftakis M. G., Mantzoros I., Zacharakis E., Raptis D., Despoudi K., et al. (2011).  The effects of the intraperitoneal administration of oxaliplatin and 5-FU on the healing of colonic anastomoses: an experimental study.. Tech Coloproctol. 15 Suppl 1, S111-5.
Pramateftakis, M. G., Kanellos D., Mantzoros I., Despoudi K., Raptis D., Angelopoulos S., et al. (2011).  Intraperitoneally administered irinotecan with 5-fluorouracil impair wound healing of colonic anastomoses in a rat model: an experimental study.. Tech Coloproctol. 15 Suppl 1, S121-5.
Papadimitriou, C. A., Papakostas P., Karina M., Malettou L., Dimopoulos M. A., Pentheroudakis G., et al. (2011).  A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.. BMC Med. 9, 10.
2010
Spanos, C. P., & Syrakos T. (2010).  Anal function and intersphincteric resection.. Dis Colon Rectum. 53(6), 958-9.
Vamvakas, L., Athanasiadis A., Karampeazis A., Kakolyris S., Polyzos A., Kouroussis C., et al. (2010).  Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG).. Crit Rev Oncol Hematol. 76(1), 61-70.
Kalofonos, H. P., Papakostas P., Makatsoris T., Papamichael D., Vourli G., Xanthakis I., et al. (2010).  Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.. Anticancer Res. 30(10), 4325-33.
2009
Maniadakis, N., Fragoulakis V., Pectasides D., & Fountzilas G. (2009).  XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis.. Curr Med Res Opin. 25(3), 797-805.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές